Gene Therapy 2002: A New Start
Following the turbulent end of the twentieth century when one protocol violation led to a most regrettable toxic death threatening clinical gene therapy in its very existence, it was hoped that easier navigation would lie ahead. Complications arising in the initial successful study of X-linked combined immune deficiency negate this hope. In this review we will produce some evidence for a promise of chances of success on a clinical level in the foreseeable future.
KeywordsGene Therapy Thymidine Kinase Glucose Dependent Insulinotropic Polypeptide Suicide Gene Suicide Gene Therapy
Unable to display preview. Download preview PDF.
- 1.Habib NA, Sarraf CE, Mitry RR et al. E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors. Hum Gene Ther 211;12:219–26.Google Scholar
- 21.Manno CS, Glader B, Ragni MV, et al. A phase I trial of AAV-mediated muscle directed gene transfer for hemophilia B. Thromb Haemost 2001;86: OC2488.Google Scholar